AEM
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AEM.02820-06v1
73/7/2054    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xie, X.
Right arrow Articles by Tang, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xie, X.
Right arrow Articles by Tang, Y.
Agricola
Right arrow Articles by Xie, X.
Right arrow Articles by Tang, Y.

 Previous Article  |  Next Article 

Applied and Environmental Microbiology, April 2007, p. 2054-2060, Vol. 73, No. 7
0099-2240/07/$08.00+0     doi:10.1128/AEM.02820-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Efficient Synthesis of Simvastatin by Use of Whole-Cell Biocatalysis{triangledown}

Xinkai Xie and Yi Tang*

Department of Chemical and Biomolecular Engineering, University of California, Los Angeles, California 90095

Received 4 December 2006/ Accepted 22 January 2007

Simvastatin is a semisynthetic derivative of the fungal polyketide lovastatin and is an important drug for lowering cholesterol levels in adults. We have developed a one-step, whole-cell biocatalytic process for the synthesis of simvastatin from monacolin J. By using an Escherichia coli strain overexpressing the previously discovered acyltransferase LovD (X. Xie, K. Watanabe, W. A. Wojcicki, C. C. Wang, and Y. Tang, Chem. Biol. 13:1161-1169, 2006), we were able to achieve >99% conversion of monacolin J to simvastatin without the use of any chemical protection steps. The key finding was a membrane-permeable substrate, {alpha}-dimethylbutyryl-S-methyl-mercaptopropionate, that was efficiently utilized by LovD as the acyl donor. The process was scaled up for gram-scale synthesis of simvastatin. We also demonstrated that simvastatin synthesized via this method can be readily purified from the fermentation broth with >90% recovery and >98% purity as determined by high-performance liquid chromatography. Bioconversion using high-cell-density, fed-batch fermentation was also examined. The whole-cell biocatalysis can therefore be an attractive alternative to currently used multistep semisynthetic transformations.

* Corresponding author. Mailing address: Department of Chemical and Biomolecular Engineering, UCLA, 5531 Boelter Hall, 420 Westwood Plaza, Los Angeles, CA 90095. Phone: (310) 825-0375. Fax: (310) 206-4107. E-mail: yitang{at}ucla.edu.

{triangledown} Published ahead of print on 2 February 2007.

Applied and Environmental Microbiology, April 2007, p. 2054-2060, Vol. 73, No. 7
0099-2240/07/$08.00+0     doi:10.1128/AEM.02820-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Microbiol. Mol. Biol. Rev. Eukaryot. Cell All ASM Journals

Copyright © 2007 by the American Society for Microbiology. All rights reserved.